These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24568253)

  • 1. Nanogel-based antigen-delivery system for nasal vaccines.
    Yuki Y; Nochi T; Kong IG; Takahashi H; Sawada S; Akiyoshi K; Kiyono H
    Biotechnol Genet Eng Rev; 2013; 29():61-72. PubMed ID: 24568253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Hum Vaccin Immunother; 2018; 14(9):2189-2193. PubMed ID: 29624474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut-associated lymphoid tissues for the development of oral vaccines.
    Kunisawa J; Kurashima Y; Kiyono H
    Adv Drug Deliv Rev; 2012 May; 64(6):523-30. PubMed ID: 21827802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses.
    Li P; Luo Z; Liu P; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Jun; 168(3):271-9. PubMed ID: 23562637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and processing of nanogels as delivery systems for peptides and proteins.
    Arnfast L; Madsen CG; Jorgensen L; Baldursdottir S
    Ther Deliv; 2014 Jun; 5(6):691-708. PubMed ID: 25090282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current advances in self-assembled nanogel delivery systems for immunotherapy.
    Tahara Y; Akiyoshi K
    Adv Drug Deliv Rev; 2015 Dec; 95():65-76. PubMed ID: 26482187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis.
    Toyoda M; Hama S; Ikeda Y; Nagasaki Y; Kogure K
    Int J Pharm; 2015 Apr; 483(1-2):110-4. PubMed ID: 25681719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
    Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
    J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routes of immunization and antigen delivery systems for optimal mucosal immune responses in humans.
    Mestecky J; Michalek SM; Moldoveanu Z; Russell MW
    Behring Inst Mitt; 1997 Feb; (98):33-43. PubMed ID: 9382757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal vaccine innovation.
    Jabbal-Gill I
    J Drug Target; 2010 Dec; 18(10):771-86. PubMed ID: 21047271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
    Azegami T; Yuki Y; Nakahashi R; Itoh H; Kiyono H
    Mol Immunol; 2018 Jun; 98():19-24. PubMed ID: 29096936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-assembled cationic nanogels for intracellular protein delivery.
    Ayame H; Morimoto N; Akiyoshi K
    Bioconjug Chem; 2008 Apr; 19(4):882-90. PubMed ID: 18336000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites.
    Debache K; Kropf C; Schütz CA; Harwood LJ; Käuper P; Monney T; Rossi N; Laue C; McCullough KC; Hemphill A
    Parasite Immunol; 2011 Feb; 33(2):81-94. PubMed ID: 21226721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyethyleneimine-based core-shell nanogels: a promising siRNA carrier for argininosuccinate synthetase mRNA knockdown in HeLa cells.
    Mimi H; Ho KM; Siu YS; Wu A; Li P
    J Control Release; 2012 Feb; 158(1):123-30. PubMed ID: 22094103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species.
    Laura Soriano Pérez M; Montironi I; Alejandro Funes J; Margineda C; Campra N; Noelia Cariddi L; José Garrido J; Molina M; Alustiza F
    Vaccine; 2024 Jun; 42(17):3721-3732. PubMed ID: 38719694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle.
    Morimoto N; Hirano S; Takahashi H; Loethen S; Thompson DH; Akiyoshi K
    Biomacromolecules; 2013 Jan; 14(1):56-63. PubMed ID: 23215439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery.
    Alpar HO; Somavarapu S; Atuah KN; Bramwell VW
    Adv Drug Deliv Rev; 2005 Jan; 57(3):411-30. PubMed ID: 15560949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways.
    Li M; Zhao M; Fu Y; Li Y; Gong T; Zhang Z; Sun X
    J Control Release; 2016 Apr; 228():9-19. PubMed ID: 26941035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New generation of mucosal adjuvants for the induction of protective immunity.
    Yuki Y; Kiyono H
    Rev Med Virol; 2003; 13(5):293-310. PubMed ID: 12931340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.